Cargando…
Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling
Objective: Bevacizumab is a recombinant humanized monoclonal antibody that blocks vascular endothelial growth factor (VEGF) with clear clinical benefits. However, overall survival of some cancer types remains low owing to resistance to bevacizumab therapy. While resistance is commonly ascribed to tu...
Autores principales: | Zhang, Xiaoling, Zhang, Yan, Jia, Yanan, Qin, Tingting, Zhang, Cuicui, Li, Yueya, Huang, Chengmou, Liu, Zhujun, Wang, Jing, Li, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309466/ https://www.ncbi.nlm.nih.gov/pubmed/32587778 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0215 |
Ejemplares similares
-
Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization
por: Lessiak, Ulrike, et al.
Publicado: (2023) -
Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells
por: Izuta, Hiroshi, et al.
Publicado: (2009) -
Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab
por: Liu, Zhujun, et al.
Publicado: (2022) -
Discovering up-regulated VEGF–C expression in swine umbilical vein endothelial cells by classical swine fever virus Shimen
por: Ning, Pengbo, et al.
Publicado: (2014) -
Proteome profiling in IL-1β and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis
por: Mohr, Thomas, et al.
Publicado: (2017)